NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, announced today that Robert Taub, Chief Executive Officer, is scheduled to give a company presentation at the Cowen and Company 28th Annual Health Care Conference on Monday, March 17, 2008 at 1:45 p.m. ET (10:45 a.m. PT) at The Boston Marriott Copley Place in Boston, Massachusetts.
